news Archives - Page 69 of 100 - Journal for Clinical Studies

Current Edition

news

Bioethics International Releases Second Good Pharma Scorecard

Bioethics International announced the second publication of its Good Pharma Scorecard ("GPS"), an annual index ranking large pharmaceutical companies and new drugs on...

13 December 2017 news clinical trial | ethics

Continue Reading →

news

Sanofi and Regeneron announce positive topline pivotal results for PD-1 antibody cemiplimab in advanced cutaneous squamous cell carcinoma

Sanofi and Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced positive topline results from a pivotal Phase 2 clinical study of cemiplimab in 82 patients ...

13 December 2017 news antibody | BLA

Continue Reading →

news

JW Pharma releases cancer treatment trial results

South Korea based JW Pharmaceuticals recently presented phase 1a/1b clinical trial results for CWP291, a target anticancer treatment that uses Wnt signaling pathway, ...

13 December 2017 news cancer | result

Continue Reading →

news

Ablynx has announced additional results from the Phase III Hercules study with caplacizumab

Ablynx NV [Euronext Brussels and Nasdaq: ABLX] today announced additional results from the Phase III HERCULES study with caplacizumab, the Company's anti-von Willebra...

13 December 2017 news aTTP | hematology

Continue Reading →

news

Targovax announces that first combination trials with ONCOS-102 have passed their initial, planned, independent safety reviews

Targovax ASA (OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, announces that clinical trials investigatin...

13 December 2017 news immuno-oncology | mesothelioma

Continue Reading →

news

Roche announces Phase III study results for the treatment of people with advanced kidney cancer

Roche has announced that the Phase III IMmotion151 study met its co-primary endpoint of investigator-assessed progression-free survival (PFS) and demonstrated that th...

13 December 2017 news chemotherapy | efficacy

Continue Reading →

news

Genoscience Pharma receives FDA approval for Phase Ib/IIa study of GNS561 in liver cancer

Genoscience Pharma, a clinical-stage biotechnology company dedicated to discovering and developing cancer treatment drugs, announces today that its most advanced comp...

6 December 2017 news . | FDA

Continue Reading →

news

Sanofi’s Toujeo® met main objective in head-to-head study versus insulin degludec

Sanofi's Toujeo® met the primary study objective in the first large head-to-head clinical trial1, called BRIGHT study, comparing Toujeo with insulin degludec. Sanofi ...

6 December 2017 news BRIGHT study | clinical trial

Continue Reading →

news

Clinerion and iHealth Group partner with Bioserv SMO to accelerate clinical research in Brazil by introducing Clinerion’s PRS to the Hospital São Vicente de Paulo

In concert with its Brazilian partner, the iHealth Group, Clinerion has agreed with Bioserv SMO to add Bioserv’s trial sites to the PRS platform. The Hospital São Vic...

6 December 2017 news clinical research | hospital

Continue Reading →

news

New Analysis Shows High Rates of Skin Clearance as Measured by Absolute PASI in Patients With Moderate to Severe Plaque Psoriasis Treated With Janssen’s TREMFYA® (guselkumab)

Janssen-Cilag International NV ("Janssen") presented a new analysis from VOYAGE 1 assessing efficacy responses based on absolute Psoriasis Area and Severity Index sco...

6 December 2017 news clinic | data

Continue Reading →